CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Publication date: Available online 7 May 2018
Source:European Journal of Cancer
Author(s): Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Roberta Carosio, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Paolo A. Ascierto, Gabriele Madonna, Ester Simeone, Federica De Galitiis, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Laura Ghilardi, Barbara Merelli, Paolo Fava, Simona Osella-Abate, Massimo Guidoboni, Massimo Romani, Diego Ferone, Francesco Spagnolo, Maria Pia Pistillo




https://ift.tt/2jG8sEZ